Susan Nemetz

Founder and CEO

Susan Nemetz is CEO and founder of The NemetzGroup and Corval. A proven leader in the life science industry, Nemetz helps transform biopharma companies from early-stage to publicly traded with her ability to see strategic opportunities and cultivate talent and empower the team to achieve them.

In 2003, Susan created The NemetzGroup, which helps companies successfully navigate the commercialization spectrum through a unique and flexible consulting model. Over the past 20 years, the company has been instrumental in guiding the evolution of more than 100 biopharma companies and the development of numerous assets, from targets to lifesaving approved medicines.

Susan founded her second company, Corval, in 2018, which is built on her deep biopharma commercialization knowledge and vision to vastly improve how emerging companies define their path to market. The company’s disruptive technology platform enables early- mid-stage biopharma companies to self-navigate the complex commercialization planning process by building a validated map, headcount, and budget plan.

Prior to establishing The NemetzGroup, Susan was Vice President of International Commercial Operations at Millennium Pharmaceuticals, Inc. She also served as Vice President of Global Commercial Strategy, leading external and internal initiatives to achieve the company's commercial vision. Susan progressed through multiple commercial leadership roles at DuPont Pharmaceuticals, culminating in her role as Executive Vice President of Cardiovascular Therapeutics and Imaging.

Susan serves as an advisor to Life Science Cares, a collective effort of the life science industry to eliminate the impact of poverty on Boston neighborhoods, and was appointed to the Board of Directors at Good Shepherd Community Care, a healthcare organization focused on hospice and palliative care.

Susan received her Bachelor of Science in Business Management from the University of Minnesota.

Marnie Hoolahan

President

Marnie brings her energy, dynamic personality, problem-solving skillset, and can-do attitude to every challenge. Her depth and breadth across the development and commercialization continuum bring a unique and refreshing perspective to her clients and budding entrepreneurs. Her direct, candid, and honest insights make her a sought out thought partner for executives.

Marnie joined The NemetzGroup in 2011, contributing over 25 years of biopharma executive-level consulting and industry experience in corporate strategy, sales, new product planning, and business development to our team and clients. Marnie’s focus has been on rare disease clients and has led a variety of Corporate, Medical Affairs, and Commercial engagements. Marnie co-authored two industry submissions to NORD (2018) on behalf of her client, X4 Pharmaceuticals, and has authored several of The NemetzGroup e-conversations.

Prior to joining The NemetzGroup, Marnie served in various roles at Genzyme Corporation, most recently as a Vice President of Business Excellence and Commercial Assessment. Marnie has also held many positions of increasing responsibility at the sales and management levels at BMS and Geltex.

Marnie Hoolahan is a member of the Life Science Cares Board of Advisors and provides Wyss Institute PhD entrepreneurs with pragmatic training for pitching their science to investors. She earned a Bachelor of Science in Marketing from Boston College and an MBA in Entrepreneurial Business and Finance from Babson College.

Colleen Moore

Executive Consultant

US and European clients value Colleen’s strategic thinking, problem-solving skills, and collaborative style. Colleen’s incredible talent to find people’s strengths, nurture them, and expertly guide them to succeed has helped her maintain long-lasting relationships with her clients.

Colleen joined The NemetzGroup in 2005. She brings over 25 years of consulting and biopharma experience in marketing, strategy development, operations, and project management within the life sciences and high-tech industries. Colleen’s keen analytical skills, collaborative problem-solving approach, and broad exposure across therapeutic areas enable an interdisciplinary approach to the key questions of commercial and brand strategy.

Prior to consulting in the biopharmaceutical industry, Colleen was the Director of Commercial Operations at Millennium Pharmaceuticals and was also integral in developing the company’s commercial, personalized medicine, and VELCADE launch strategies. Colleen also held business leadership roles at Scient Corporation, Microsoft, and Digital Equipment Corporation (now Hewlett Packard).

Colleen earned her Bachelor of Science in Finance from Boston College and an MBA from MIT Sloan School of Management.

Lori Horvat

Senior Consultant

Lori has extensive experience supporting and launching assets in oncology and is passionate about leveraging actionable insights to make sound business decisions. Lori’s leadership skills and collaborative spirit help drive effective teamwork and achievement of corporate goals.

Lori joined The NemetzGroup in 2016 with over 20 years of industry and consulting experience in oncology and global marketing. Her expertise includes new product planning, lifecycle management, brand strategy and execution, business development, and asset valuation. Lori is a highly effective leader with skills that range the commercialization spectrum.

She successfully launched many therapies while at ARIAD, where she was VP of Marketing, responsible for Global Marketing, US Marketing, and Global Commercial Analytics. Additionally, she was a member of the Joint Development & Commercialization Committee for the ARIAD/Otsuka Alliance in Japan.

Lori received her BS from the United States Naval Academy, her MS from Central Michigan University, and an MBA from Harvard Business School.

Meighan Rock

Senior Consultant

Meighan has the unique ability to simultaneously communicate the big-picture strategy and identify the tactical requirements to achieve results. Her keen analytical skills, collaborative problem-solving approach, and broad exposure across therapeutic areas enable an interdisciplinary approach to the key questions of commercial and medical affairs strategy.

Meighan joined The NemetzGroup in 2015. She has over 20 years of industry and consulting experience in new product planning, commercial assessment, business development, and global marketing strategy. She understands how to build teams and work cross-functionally from clinical to market access to lifecycle management with a US and global perspective.

As Director of Renal Global Strategy at Sanofi, Meighan oversaw the marketing and communications strategy, primary market research, business development support, and competitive intelligence. Meighan spent several years as the commercial lead for a portfolio of clinical and preclinical rare disease programs tasked with providing market and indication analyses to drive asset prioritization at Sanofi and Genzyme.

Meighan holds a BA from Hampshire College and an MLIS from the University of Illinois and has completed coursework in Epidemiology/Biostatistics at Tufts Medical School.

Liz Tufo

Senior Consultant

Liz creates structure throughout all levels of an organization by helping leaders define their objectives, drill down on the critical priorities, and execute against them to achieve success.

Liz joined The NemetzGroup in 2014 with a collective consulting, marketing, and client management history of over 15 years. Liz is able to navigate the dynamic industry to adapt to the evolving needs of our clients while defining “right-sized” recommendations to meet your objectives. In her tenure at The NemetzGroup, Liz has managed both strategic and tactical initiatives for clients, including market research, brand planning, commercialization mapping, and organizational planning. Liz also often plays a role in defining long-range planning processes and functional plans to build the organization to achieve its goals successfully. Liz is highly valued as an embedded resource on our team for her ability to help clients focus on critical priorities to achieve their leadership objectives.

She has a background in professional marketing across life science and healthcare provider organizations through her tenure at White Rhino and LehmanMillet (now known as PrecisionEffect).

Liz holds a Bachelor of Science in Communications from Suffolk University and an MBA from Bentley University.

Jim Whalen

Senior Consultant

Jim excels at disruptive strategy and brand positioning in challenging markets. He uses his scientific acumen to translate insights into actionable commercial implications. His experience enables him to effectively bridge the diverse functions across development and commercial teams by speaking their language to gain alignment.

Jim joined The NemetzGroup in 2011 and has over 35 years of broad industry and consulting experience. His background includes product development strategy, new product and lifecycle planning, global product launches, and market analysis. His considerable knowledge of oncology, orphan diseases, and specialty markets, plus his ability to facilitate engaging workshops, has made Jim a valued asset for our clients.

He began his career at Hoffmann-La Roche with positions in sales, market research, regulatory affairs, and business development before joining Genetics Institute (GI) as a marketing manager. He eventually rose to Director of Oncology Marketing and was responsible for launching the company’s first oncology product. Jim joined Wyeth as Senior Director of Global Strategic Marketing, responsible for several global franchises and preparation for the international launch of what is now an >$4 BN global brand.

Jim has an undergraduate degree in Biological Science with a minor in Chemistry.

Marianne Doherty

Consultant

Marianne applies practical approaches and an operational mindset to create efficiencies and new ways of working that have a lasting impact for our clients. Marianne develops effective solutions and drives process improvements for essential business processes that contribute to successful commercialization.

Marianne joined The NemetzGroup in 2018 with over 20 years of consulting and industry experience in sales, marketing, and commercial operations. With a collaborative style and focus on results, Marianne is skilled at bringing cross-functional teams together and directing the effort through the critical phases of commercialization, including launch strategy, tactical planning and execution, and field deployment. At The NemetzGroup, she introduces customized frameworks and leverages technology to support essential processes, including MLR review, KOL engagement, congress planning, launch planning, and more.

After building a strong foundation in sales, marketing, and field operations at Novartis Pharmaceuticals, Marianne led the development of commercial capabilities and field infrastructure to enable launch success for Vertex and Merrimack Pharmaceuticals, both emerging biopharma companies launching their first products.

Marianne is a long-time Healthcare Businesswomen’s Association member with a Bachelor of Science in Business Administration.

Victor Liang

Consultant

Victor combines broad industry experience, an analytical mindset, and a thoughtful, collaborative style to realize best-in-class insight-driven strategies and execution.

Victor joined The NemetzGroup in 2021 with almost 20 years in consulting and biopharma industry roles. He brings commercial and entrepreneurial experience spanning multiple industries and a diverse range of global and US functions. His expertise includes brand strategy, brand operational planning, business insight and analytics, forecasting, lifecycle management, business development, program management, sales operations, and advanced analytics.

At AstraZeneca and Shire Pharmaceuticals, Victor gained experience across numerous product launches and therapeutic areas (oncology, GI, rare disease, diabetes, respiratory, and CNS). He helped the organizations maximize brand value by realizing best-in-class launch and post-launch growth strategy and execution while building commercial capabilities to ensure that every appropriate patient had access to life-changing medicines.
Prior to entering the biopharma industry, Victor was an entrepreneur who founded a boutique consulting group that helped organizations work more effectively and a community bank that better served the small business community than traditional banks. In addition, he served as an advisor to tech startups and was a speaker on building successful small businesses.

Victor holds a Bachelor of Science in Electrical Engineering from Carnegie Mellon University.

Ray Mankoski, MD, PhD

Consultant

Ray is an optimistic, enthusiastic, strategic builder and leader who is always ready to roll up his sleeves and get things done. He combines deep industry expertise and a commitment to continuous learning in a rapidly changing healthcare environment with his passion for advancing patient care.

Ray joined The NemetzGroup in 2021 with over 15 years of experience in the biopharma industry. He is a strategic Medical Affairs leader with a career spanning big pharma and small biotech in US- and Global-focused roles across oncology, rare disease, pediatrics, and neuropsychiatry. From basic research experience to real-world evidence generation supporting regulatory approvals to building medical affairs organizations and long-range strategic planning, Ray brings our clients scientific, clinical, medical, and HEOR expertise.

Ray began his career at BMS and then Genzyme, leading the development of strategic medical affairs plans and activities for launches of multiple therapies to treat both rare and common conditions. As part of his training and within the pharmaceutical industry, Ray has hands-on interventional and observational research experience and successful engagements with health authorities and health technology assessors. Later in his career at Epizyme and Blueprint, Ray built two Medical Affairs organizations from the ground up, establishing and overseeing multiple critical functions, including medical/scientific communications, key opinion leader engagement and medical science liaisons (MSLs), health economics and outcomes research, preapproval access programs, investigator-initiated studies, and medical information.

Ray is a member of the Medical Affairs Society and the International Society for Pharmacoeconomics and Outcomes Research. He received his MD from Tufts University School of Medicine and his PhD in Genetics from the Tufts School of Graduate Biomedical Sciences.

Kristin Owens

Consultant

Kristin blends deep industry knowledge, keen business savvy, and creative, strategic thinking with an engaging interpersonal style, collaborative approach, and contagious enthusiasm.

Kristin joined The NemetzGroup in 2020 with over 20 years of consulting and biopharma industry experience as an accomplished, results-oriented, and strategic commercial leader. Her expertise includes sales, operations, lifecycle management, brand strategy and execution, and business development. Kristin is a hands-on team leader and inspiring motivator with excellent analytical, problem-solving, and communication skills.

At Sanofi, Kristin led business units across numerous therapeutic areas in both broad-spectrum and rare diseases. She managed portfolios from launch through authorized generics and appreciates the need for a long-term, proactive approach to lifecycle management.

Kristin holds a BA in Economics from Boston College and an MBA in Finance from Villanova University.

Donna Fogg

Senior Manager,
Finance and Operations

Donna’s positive, can-do spirit and ability to work cross-functionally make her a vital “go-to” team member.

Donna joined the NemetzGroup in 2017 after spending 15 years organizing and maintaining the business for a Financial Advisor. As Finance and Operations Manager, Donna is responsible for the day-to-day financial functions of the organization and assists with the benefits and operational logistics.

Prior experience includes working in the finance department of a manufacturing company responsible for accounts payable, accounts receivable, and payroll.

Donna received a Paralegal Degree and an Accounting Certificate.

Ellen Keane

Marketing and Communications

Ellen brings proactive engagement, positive energy, and incredible rigor to our team. Her broad biopharma experience helps align client-facing initiatives and internal business operations while providing collaborative support and resourcefulness.

Ellen joined the NemetzGroup in 2013 and brings three decades of commercial experience in brand strategy, launch planning and execution, medical education, and senior leadership. Leading the marketing and communications at The NemetzGroup, Ellen contributes her organizational build and commercialization skills and works seamlessly with business operations.

Ellen began her pharma career at Marion Laboratories (a founding branch of Sanofi Aventis) and progressed through leadership positions within sales, sales training, and product marketing for multiple brands. She moved to senior leadership positions for startup franchises at Genentech and AAI Pharma before joining Endo Pharmaceuticals. As Director of Specialty Sales, Ellen led the launches of numerous brands across multiple therapeutic areas and developed high-performing teams to consistently achieve financial results.

Earning a BA in Nursing, Ellen’s early career as a registered nurse at an urban trauma center provided a strong clinical and patient-centered foundation.

Regan Weldy

Associate Director, Creative

Regan is a creative problem solver trusted to execute a new approach to design and way of working. Her expertise lies in elevating visual stories and driving brands forward by challenging the status quo while staying true to the brand’s core, being data-driven, and responding to business needs.

Regan joined The NemetzGroup in 2021. She is a hands-on, creative director with over 20 years of experience as a graphic designer, delivering best-in-class design for brand development, sales and marketing materials, presentations, event support, digital marketing, etc. – from concept through activation – across audiences, channels, and mediums. She excels at developing new strategies to manage complex projects and clearly defining best practices, policies, and tools.

Before joining the company, Regan worked as an in-house Associate Creative Director at Informa Tech, where she guided strategic and conceptual creative thinking for 15+ B2B and B2C tech and media brands, including setting visual brand direction and ensuring creative deliverables met expectations by providing specific and actionable feedback. Prior to Informa Tech, Regan held various roles of increasing responsibility, most notably at TEKsystems, Gryphon Technologies, and The Design Block. She is passionate about growing and developing incredible creative professionals while fostering an inclusive and collaborative team culture.